AccuStem Sciences, Inc. ACUT

Set alert

Price alert · ACUT

All alert types
0.13 USD -0.02 -13.33%

At close · Oct 29

0.15 Day range 0.15
0.117 52-week range 1.24
YTD
-84.02%
1 year
-89.52%
Open
0.15
Prev close
0.15
Mkt cap
2.09M
Vol
4
Avg vol
2.68K
EPS
-0.11
P/E
0.00
More statistics
Low
0.15
High
0.15

5D chart

Chart tools
Interval
ACUT five-day price chart0.130.140.150.150.16Oct 26Oct 27Oct 29

Financial health

Altman Z-Score

-16.69 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -6.8×
FY 2020: -417×FY 2021: -33.8×FY 2022: -4.0×FY 2023: -3.5×FY 2024: -3.4×FY 2025: -6.8×
FY 2020 5y median -4.0× FY 2025
P/S 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
P/B -3.6×
FY 2020: 15.0×FY 2021: 26.5×FY 2022: -107×FY 2023: -3.4×FY 2024: -1.5×FY 2025: -3.6×
FY 2020 5y median -3.4× FY 2025
P/FCF -14.6×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: -8.2×FY 2023: -4.4×FY 2024: -7.7×FY 2025: -14.6×
FY 2020 5y median -7.7× FY 2025
EV/EBITDA -7.1×
FY 2020: 545×FY 2021: -58741×FY 2022: -3.8×FY 2023: -3.5×FY 2024: -3.4×FY 2025: -7.1×
FY 2020 5y median -3.8× FY 2025
EV/Sales 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -6.9%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: -12.2%FY 2023: -22.8%FY 2024: -13.0%FY 2025: -6.9%
FY 2020 5y median -12.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
ROE 51.6%
FY 2020: -3.6%FY 2021: -78.4%FY 2022: 2684.3%FY 2023: 97.1%FY 2024: 45.4%FY 2025: 51.6%
FY 2020 5y median 51.6% FY 2025
ROIC 52.0%
FY 2020: -3.6%FY 2021: -78.4%FY 2022: 11351.5%FY 2023: 99.8%FY 2024: 45.8%FY 2025: 52.0%
FY 2020 5y median 52.0% FY 2025
ROA -113.3%
FY 2020: -3.5%FY 2021: -43.1%FY 2022: -398.6%FY 2023: -1531.8%FY 2024: -2959.6%FY 2025: -113.3%
FY 2020 5y median -398.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 FY 2025
Operating Income -16.7%
FY 2020: 0.0%FY 2021: -1136.9%FY 2022: -458.3%FY 2023: 45.2%FY 2024: 26.6%FY 2025: -16.7%
FY 2020 FY 2025
EPS (diluted) 7.7%
FY 2020: 0.0%FY 2021: -1133.3%FY 2022: -474.3%FY 2023: 47.1%FY 2024: 27.8%FY 2025: 7.7%
FY 2020 FY 2025
Free Cash Flow -28.1%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 11.1%FY 2024: 58.9%FY 2025: -28.1%
FY 2020 FY 2025

Financial Health

Current Ratio 0.0×
FY 2020: 24.7×FY 2021: 1.9×FY 2022: 0.9×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.1× FY 2025
Quick Ratio 0.0×
FY 2020: 24.7×FY 2021: 1.9×FY 2022: 0.9×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.1× FY 2025
Debt / Equity -0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: -0.8×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.0×
FY 2020 5y median -0.0× FY 2025
Net Debt / EBITDA -0.0×
FY 2020: -40.6×FY 2021: 0.0×FY 2022: 0.2×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.0×
FY 2020 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31